The global molecular weight marker market size was valued at USD 355.2 million in 2016 and is projected to grow at 14.1% over the forecast period. The increased popularity of personalized medicines for the treatment of chronic diseases and genetic disorders is a major factor contributing to the growth of the market. Personalized medicines involve the application of molecular weight markers for the study of an individual’s genome, genes, and diseases. Thus, the growing adoption of personalized medicines along with an escalating focus on molecular biology research is expected to boost the demand for molecular weight marker products.
Technological advancement in molecular biology products, such as PCR and NGS along with high-quality molecular weight marker is another major factor contributing toward growth. The recent advancement in these products enables the provision of a clearer background and sharp bands. Thus, the demand for molecular weight marker products is expected upsurge in the near future, which is expected to boost growth.
U.S. molecular weight marker market, by product, 2014 - 2025 (USD Million)
On the basis of the product, the market is segmented into DNA markers, protein markers, and RNA markers. In 2016, the DNA markers segment was the largest revenue-grossing segment and is estimated to grow at a significant CAGR during the forecast period. Rising R&D activities related to genomics research boosts the demand for DNA markers for genome mapping.
The protein markers segment is expected to display lucrative growth during the forecast period, due to the rising application of these products for proteomics study. The researchers and biotechnology companies are focusing on the application of proteomics study for new drug discovery and clinical diagnostics.
Based on the type, the molecular weight marker market has been segmented into prestained, unstained, and specialty markers. Prestained markers were the highest revenue-generating segment in 2016, due to the large application of this product for genomics and proteomics research.
The unstained markers segment is projected to showcase significant growth during the study period. This is due to its ability to provide more accurate molecular weight determinations of the sample over a wide molecular weight range. Thus, the popularity of this product is increasing, which is expected to propel the growth of the market.
Molecular weight marker has applications in nucleic acid and proteomics study. The nucleic acid segment dominated the sector in 2016 due to an increasing focus on DNA- and RNA-based research. The rising demand for advanced diagnostics and therapeutics products has led to an increased focus on genomics research.
The proteomics application segment is expected to be the fastest-growing segment by 2025. Escalating application of western blotting and gel extraction for proteomics research including drug discovery & clinical diagnostics drives the growth of the market.
North America molecular weight marker market share, by application, 2016
The academic & research institutes segment held the largest revenue share due to rising funding for molecular biology research by private and government organizations. There is a growing focus on research-based on genomics such as genotyping, cytogenomics, gene expression, epigenetic analysis, and transcriptome analysis, which is boosting the application of molecular weight markers in academic & research institutes.
The pharmaceutical and biotechnology companies segment is expected to witness significant CAGR over the forecast period due to the rising investment in R&D for new drug development. Hence, there is an increasing need for molecular weight markers in these companies, which is projected to propel the growth of the market.
North America dominated the molecular weight markers industry with the largest revenue share, owing to the presence of many large research laboratories and biotechnology firms such as CELGENE CORP. and Amgen Inc. in this region. In addition, the highly developed healthcare and research infrastructure in this region have fueled market growth.
Asia Pacific is estimated to exhibit the highest CAGR during the forecast period, owing to the rising focus of CROs and biotechnology companies in this region for drug discovery and development. The CROs are focusing on Asian countries such as China and India for clinical trials owing to less stringent government regulations and the availability of skilled professionals. These are some of the factors projected to boost regional market growth.
Some of the key players are Thermo Fisher Scientific, Inc.; F Hoffmann-La Roche Ltd; Merck KGaA; Agilent Technologies; QIAGEN; TAKARA BIO, INC.; Bio-Rad Laboratories, Inc.; Promega Corp; and New England Biolabs.
The market is competitive in nature as major players are involved in new product development, mergers, collaborations, acquisitions, and regional expansion to aid market penetration. Increasing adoption of outsourcing is expected to increase industry rivalry in the near future. Strategic acquisitions help companies to expand their existing product portfolio and geographical reach. For instance, in November 2015, Merck KGaA completed the acquisition of Sigma-Aldrich Co. LLC. for USD 17 billion to strengthen its life science business.
Base year for estimation
Actual estimates/Historic data
2014 - 2015
2017 - 2025
Revenue in USD Million & CAGR from 2017 to 2025
North America, Europe, Asia Pacific, Latin America & MEA
U.S., Canada, U.K., Germany, Japan, India, China, Brazil, Mexico, South Africa
Revenue forecast, company share, competitive landscape, growth factors and trends
15% free customization scope (equivalent to 5 analyst working days)
If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the molecular weight marker market on the basis of product, type, application, end-use, and region:
Product Outlook (Revenue, USD Million; 2014 - 2025)
Below 50 bp
50 bp to 100 bp
100 bp to 1 kb
1 kb to 5 kb
Above 5 kb
Below 10 kDa
10 k Da to 100 kDa
100 k Da to 200 kDa
Above 200 kDa
Type Outlook (Revenue, USD Million; 2014 - 2025)
Application Outlook (Revenue, USD Million; 2014 - 2025)
Nucleic acid applications
End-use Outlook (Revenue, USD Million; 2014 - 2025)
Academic and research institutes
Pharmaceutical and biotechnology companies
Regional Outlook (Revenue, USD Million; 2014 - 2025)
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
Biopharmaceutical innovators are at the forefront of the human response to the coronavirus pandemic. A significant number of major biotech firms are in the midst of a race to investigate the Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the speed of response to SARS/MERs etc, the biotech entities are investigating SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are being put into the R&D. With multiple candidates in trial, the public and private sectors are anticipated to work in unison for the foreseeable period, until a vaccine is developed for Covid-19. The report will account for Covid19 as a key market contributor.